The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Marine Omega-3 (N-3) Fatty Acids for Cardiovascular Health: An Update for 2020
Open accessAbstract
The omega-3 (n-3) fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are found in seafood (especially fatty fish), supplements and concentrated pharmaceutical preparations. Long-term prospective cohort studies consistently demonstrate an association between higher intakes of fish, fatty fish and marine n-3 fatty acids (EPA + DHA) or higher levels of EPA and DHA in the body and lower risk of developing cardiovascular disease (CVD), especially coronary heart disease (CHD) and myocardial infarction (MI), and cardiovascular mortality in the general population. This cardioprotective effect of EPA and DHA is most likely due to the beneficial modulation of a number of known risk factors for CVD, such as blood lipids, blood pressure, heart rate and heart rate variability, platelet aggregation, endothelial function, and inflammation. Evidence for primary prevention of CVD through randomised controlled trials (RCTs) is relatively weak. In high-risk patients, especially in the secondary prevention setting (e.g., post-MI), a number of large RCTs support the use of EPA + DHA (or EPA alone) as confirmed through a recent meta-analysis. This review presents some of the key studies that have investigated EPA and DHA in the primary and secondary prevention of CVD, describes potential mechanisms for their cardioprotective effect, and evaluates the more recently published RCTs in the context of existing scientific literature.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
Kris-Etherton, P. M., Harris, W. S., & Appel, L. J. (2002) · Circulation · doi:10.1161/01.cir.0000038493.65177.94 · Cited by 3,707
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610
Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516
(1999) · PubMed · Cited by 2,062
GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61239-8 · Cited by 1,350
Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014682.14181.f2 · Cited by 1,311 · cited 1×
“The beneficial effect of EPA + DHA on total mortality and sudden cardiac death was observed after 3 months and 4 months of supplementation, respectively, and raised interest in the potential anti-arrhythmic action of EPA and DHA [57].”
BackgroundDistribution, interconversion, and dose response of n-3 fatty acids in humans.
Arterburn, L. M., Hall, E. B., & Oken, H. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1467s · Cited by 1,162
Blood Levels of Long-Chain n–3 Fatty Acids and the Risk of Sudden Death
Albert, C. M., Campos, H., Stampfer, M. J., Ridker, P. M., Manson, J. E., Willett, W. C., & Ma, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012918 · Cited by 1,146
Chowdhury, R., Warnakula, S., Kunutsor, S., Crowe, F., Ward, H. A., Johnson, L., Franco, O. H., Butterworth, A. S., Forouhi, N. G., Thompson, S. G., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1788 · Cited by 1,139
The Omega-3 Index: A new risk factor for death from coronary heart disease?
Harris, W. S., & von Schacky, C. (2004) · Preventive Medicine · doi:10.1016/j.ypmed.2004.02.030 · Cited by 1,111
Fish and Omega-3 Fatty Acid Intake and Risk of Coronary Heart Disease in Women
Hu, F. B. (2002) · JAMA · doi:10.1001/jama.287.14.1815 · Cited by 1,018
Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
Manson, J. E., Cook, N. R., Lee, I.-M., Christen, W., Bassuk, S. S., Mora, S., Gibson, H., Albert, C. M., Gordon, D., Copeland, T., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811403 · Cited by 979 · cited 3×
“The Vitamin D and Omega-3 Trial (VITAL) trial randomised 25,871 healthy participants aged over 50 years (men) and 55 years (women) to receive marine n-3 fatty acids (840 mg/d EPA+DHA) and/or vitamin D (2000 IU/d) or placebo [54].”
BackgroundRizos, E. C., Ntzani, E. E., Bika, E., Kostapanos, M. S., & Elisaf, M. S. (2012) · JAMA · doi:10.1001/2012.jama.11374 · Cited by 960
The Composition of Food Consumed by Greenland Eskimos
Bang, H. O., Dyerberg, J., & Hjørne, N. (1976) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1976.tb08198.x · Cited by 944
n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
Kromhout, D., Giltay, E. J., & Geleijnse, J. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003603 · Cited by 936
n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203859 · Cited by 929
Kromann, N., & Green, A. (1980) · PubMed · Cited by 851
Bucher, H. C., Hengstler, P., Schindler, C., & Meier, G. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)01114-7 · Cited by 823
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Cardiology · doi:10.1159/000346463 · Cited by 748
Kromann, N., & Green, A. (1980) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1980.tb01221.x · Cited by 713
Effects of n−3 Fatty Acid Supplements in Diabetes Mellitus
The ASCEND Study Collaborative Group (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804989 · Cited by 698
Aung, T., Halsey, J., Kromhout, D., Gerstein, H. C., Marchioli, R., Tavazzi, L., Geleijnse, J. M., Rauch, B., Ness, A., Galan, P., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2017.5205 · Cited by 632
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub3 · Cited by 630
Siscovick, D. S., Barringer, T. A., Fretts, A. M., Wu, J. H. Y., Lichtenstein, A. H., Costello, R. B., Kris-Etherton, P. M., Jacobson, T. A., Engler, M. B., Alger, H. M., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000482 · Cited by 629
Rauch, B., Schiele, R., Schneider, S., Diller, F., Victor, N., Gohlke, H., Gottwik, M., Steinbeck, G., Del Castillo, U., Sack, R., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.948562 · Cited by 607 · cited 1×
“The OMEGA study investigated the effect of supplementation with 840 mg/d EPA + DHA for 1 year in 3,851 early post-MI patients, with the primary endpoint of sudden cardiac death [64].”
MethodDietary intakes and food sources of omega‐6 and omega‐3 polyunsaturated fatty acids
Meyer, B. J., Mann, N. J., Lewis, J. L., Milligan, G. C., Sinclair, A. J., & Howe, P. R. C. (2003) · Lipids · doi:10.1007/s11745-003-1074-0 · Cited by 595
Mori, T. A., Burke, V., Puddey, I. B., Watts, G. F., O’Neal, D. N., Best, J. D., & Beilin, L. J. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.5.1085 · Cited by 588
n–3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored
CALDER, P. C. (2004) · Clinical Science · doi:10.1042/cs20040119 · Cited by 560
Self-citationSkulas-Ray, A. C., Wilson, P. W. F., Harris, W. S., Brinton, E. A., Kris-Etherton, P. M., Richter, C. K., Jacobson, T. A., Engler, M. B., Miller, M., Robinson, J. G., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000709 · Cited by 512
n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
The Risk and Prevention Study Collaborative Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205409 · Cited by 510
Rimm, E. B., Appel, L. J., Chiuve, S. E., Djoussé, L., Engler, M. B., Kris-Etherton, P. M., Mozaffarian, D., Siscovick, D. S., Lichtenstein, A. H., & On behalf of the American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Epidemiology and Prevention; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology (2018) · Circulation · doi:10.1161/cir.0000000000000574 · Cited by 500
Metabolism and functional effects of plant-derived omega-3 fatty acids in humans
Baker, E. J., Miles, E. A., Burdge, G. C., Yaqoob, P., & Calder, P. C. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.07.002 · Cited by 472
Self-citationGalan, P., Kesse-Guyot, E., Czernichow, S., Briancon, S., Blacher, J., Hercberg, S., & for the SU.FOL.OM3 Collaborative Group (2010) · BMJ · doi:10.1136/bmj.c6273 · Cited by 457
Very long-chain n -3 fatty acids and human health: fact, fiction and the future
Calder, P. C. (2018) · Proceedings of the Nutrition Society · doi:10.1017/s0029665117003950 · Cited by 419
Self-citationMori, T. A., Bao, D. Q., Burke, V., Puddey, I. B., & Beilin, L. J. (1999) · Hypertension · doi:10.1161/01.hyp.34.2.253 · Cited by 407
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub4 · Cited by 405
Del Gobbo, L. C., Imamura, F., Aslibekyan, S., Marklund, M., Virtanen, J. K., Wennberg, M., Yakoob, M. Y., Chiuve, S. E., dela Cruz, L., Frazier-Wood, A. C., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.2925 · Cited by 404
Effect of Fish Oil on Heart Rate in Humans: A Meta-Analysis of Randomized Controlled Trials
Mozaffarian, D., Geelen, A., Brouwer, I. A., Geleijnse, J. M., Zock, P. L., & Katan, M. B. (2005) · Circulation · doi:10.1161/circulationaha.105.556886 · Cited by 399
Hu, Y., Hu, F. B., & Manson, J. E. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013543 · Cited by 388
Kwak (2012) · doi:10.1001/archinternmed.2012.262 · Cited by 368
Mori, T. A., Watts, G. F., Burke, V., Hilme, E., Puddey, I. B., & Beilin, L. J. (2000) · Circulation · doi:10.1161/01.cir.102.11.1264 · Cited by 360
Bioavailability of long-chain omega-3 fatty acids
Schuchardt, J. P., & Hahn, A. (2013) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2013.03.010 · Cited by 344
Woodman, R. J., Mori, T. A., Burke, V., Puddey, I. B., Watts, G. F., & Beilin, L. J. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.5.1007 · Cited by 338 · cited 1×
“Whilst neither EPA nor DHA affected total cholesterol concentrations to a significant degree, there was an independent effect on other blood lipid parameters, with EPA lowering the HDL3-cholesterol subfraction and DHA increasing the more cardioprotective HDL2-cholesterol [40,41].”
BackgroundMiller, P. E., Van Elswyk, M., & Alexander, D. D. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu024 · Cited by 338
Docosapentaenoic acid (22:5n-3): A review of its biological effects
Kaur, G., Cameron-Smith, D., Garg, M., & Sinclair, A. J. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.07.004 · Cited by 337
Omega‐3 Dietary Supplements and the Risk of Cardiovascular Events: A Systematic Review
Marik, P. E., & Varon, J. (2009) · Clinical Cardiology · doi:10.1002/clc.20604 · Cited by 328
Dietary intake of long-chain ω-3 polyunsaturated fatty acids: contribution of meat sources
Howe, P., Meyer, B., Record, S., & Baghurst, K. (2006) · Nutrition · doi:10.1016/j.nut.2005.05.009 · Cited by 325
Mori, T. A., Woodman, R. J., Burke, V., Puddey, I. B., Croft, K. D., & Beilin, L. J. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00407-6 · Cited by 322
Effect of Different Antilipidemic Agents and Diets on Mortality: A Systematic Review
Studer, M., Briel, M., Leimenstoll, B., Glass, T. R., & Bucher, H. C. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.7.725 · Cited by 318
Browning, L. M., Walker, C. G., Mander, A. P., West, A. L., Madden, J., Gambell, J. M., Young, S., Wang, L., Jebb, S. A., & Calder, P. C. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.041343 · Cited by 314
Self-citationGrimsgaard, S., Bonaa, K., Hansen, J., & Nordøy, A. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/66.3.649 · Cited by 300
Nestel, P., Shige, H., Pomeroy, S., Cehun, M., Abbey, M., & Raederstorff, D. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.2.326 · Cited by 263
Allaire, J., Couture, P., Leclerc, M., Charest, A., Marin, J., Lépine, M.-C., Talbot, D., Tchernof, A., & Lamarche, B. (2016) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.131896 · Cited by 252
Alexander, D. D., Miller, P. E., Van Elswyk, M. E., Kuratko, C. N., & Bylsma, L. C. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.10.018 · Cited by 251
Wang, Q., Liang, X., Wang, L., Lu, X., Huang, J., Cao, J., Li, H., & Gu, D. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.01.006 · Cited by 233
Li, K., Huang, T., Zheng, J., Wu, K., & Li, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088103 · Cited by 226
Relationships between plasma fatty acid composition and coronary artery disease.
Itakura, H., Yokoyama, M., Matsuzaki, M., Saito, Y., Origasa, H., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Kita, T., et al. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.5876 · Cited by 218
Omega 3 Fatty Acids and Cardiovascular Outcomes: Systematic Review and Meta-Analysis
Kotwal, S., Jun, M., Sullivan, D., Perkovic, V., & Neal, B. (2012) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.112.966168 · Cited by 201
Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans
Grimsgaard, S., Bønaa, K. H., Hansen, J.-B., & Myhre, E. S. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.1.52 · Cited by 201
Innes, J. K., & Calder, P. C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020532 · Cited by 201
Self-citationWoodman, R. J., Mori, T. A., Burke, V., Puddey, I. B., Barden, A., Watts, G. F., & Beilin, L. J. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00307-6 · Cited by 199
Harris, W. S., Del Gobbo, L., & Tintle, N. L. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.05.007 · Cited by 183 · cited 1×
“[25] used data from 10 cohort studies and identified a 15% reduction in risk of fatal CHD for each one standard deviation increase in omega-3 index.”
MethodMortality from Ischaemic Heart Disease and Cerebrovascular Disease in Greenland
BJERREGAARD, P., & DYERBERG, J. (1988) · International Journal of Epidemiology · doi:10.1093/ije/17.3.514 · Cited by 175
Fish consumption, omega-3 fatty acids and risk of heart failure: A meta-analysis
Djoussé, L., Akinkuolie, A. O., Wu, J. H. Y., Ding, E. L., & Gaziano, J. M. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.05.010 · Cited by 168 · cited 1×
“These include a 2012 aggregation of seven prospective cohort studies, including 176,441 participants, which investigated the association between dietary fish, EPA+DHA intake or plasma EPA + DHA concentrations and heart failure [20].”
BackgroundCasula, M., Soranna, D., Catapano, A. L., & Corrao, G. (2013) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(13)70005-9 · Cited by 152 · cited 2×
“, 2013 [75] 11 RCTs (up to March 2013) representing 15,348 patients with CVD Supplemental marine n-3 fatty acids with a dose range of 1–6 g/d EPA + DHA ≥ 1 year (duration ranged from 1–3.”
BackgroundMethodAtherosclerosis in Alaska Natives and non-natives
Newman, W. P., Middaugh, J. P., Propst, M. T., & Rogers, D. R. (1993) · The Lancet · doi:10.1016/0140-6736(93)92413-n · Cited by 145
Pase, M. P., Grima, N., & Sarris, J. J. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511002819 · Cited by 127
Mori, T. A., Puddey, I. B., Burke, V., Croft, K. D., Dunstan, D. W., Rivera, J. H., & Beilin, L. J. (2000) · Redox Report · doi:10.1179/rer.2000.5.1.45 · Cited by 124
AbuMweis, S., Jew, S., Tayyem, R., & Agraib, L. (2018) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12493 · Cited by 122
Maki, K. C., Palacios, O. M., Bell, M., & Toth, P. P. (2017) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2017.07.010 · Cited by 107
Mas, E., Woodman, R. J., Burke, V., Puddey, I. B., Beilin, L. J., Durand, T., & Mori, T. A. (2010) · Free Radical Research · doi:10.3109/10715762.2010.492830 · Cited by 107
Marine omega-3 fatty acids and coronary heart disease
Calder, P. C., & Yaqoob, P. (2012) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328353febd · Cited by 103
Self-citationOrringer, C. E., Jacobson, T. A., & Maki, K. C. (2019) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2019.10.014 · Cited by 103
Gao, L.-G., Cao, J., Mao, Q., Lu, X., Zhou, X., & Fan, L. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.10.056 · Cited by 101
Omega-3 fatty Acids in cardiovascular disease – An uphill battle
von Schacky, C. (2014) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2014.05.004 · Cited by 101
Einvik, G., Klemsdal, T. O., Sandvik, L., & Hjerkinn, E. M. (2010) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e328339cc70 · Cited by 100
Wen, Y. T., Dai, J. H., & Gao, Q. (2014) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.12.004 · Cited by 98
Zhang, Y., Zhuang, P., He, W., Chen, J. N., Wang, W., Freedman, N. D., Abnet, C. C., Wang, J. B., & Jiao, J. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12786 · Cited by 98
Yano, K., MacLean, C. J., REED, D. M., Shimizu, Y., Sasaki, H., Kodama, K., Kato, H., & Kagan, A. (1988) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114824 · Cited by 95
Zhao, Y.-T., Chen, Q., Sun, Y.-X., Li, X.-B., Zhang, P., Xu, Y., & Guo, J.-H. (2009) · Annals of Medicine · doi:10.1080/07853890802698834 · Cited by 94
Xin, W., Wei, W., & Li, X.-Y. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.049833 · Cited by 80
EPA, but not DHA, decreases mean platelet volume in normal subjects
Park, Y., & Harris, W. S. (2002) · Lipids · doi:10.1007/s11745-006-0984-1 · Cited by 71
Jiang, J., Li, K., Wang, F., Yang, B., Fu, Y., Zheng, J., & Li, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147351 · Cited by 70
EFSA Panel on Dietetic Products, N. A. A. (. (2010) · EFSA Journal · doi:10.2903/j.efsa.2010.1796 · Cited by 65
Xin, W., Wei, W., & Li, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046028 · Cited by 63
Rice, H. B., Bernasconi, A. A., Maki, K. C., Harris, W. S., von Schacky, C., & Calder, P. C. (2016) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2016.01.003 · Cited by 63
Self-citationVors, C., Allaire, J., Marin, J., Lépine, M.-C., Charest, A., Tchernof, A., Couture, P., & Lamarche, B. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.01.025 · Cited by 48
Hidayat, K., Yang, J., Zhang, Z., Chen, G., Qin, L., Eggersdorfer, M. L., & Zhang, W. (2017) · European Journal of Clinical Nutrition · doi:10.1038/s41430-017-0052-3 · Cited by 46
Trikalinos, T. A., Lee, J., Moorthy, D., Yu, W. W., Lau, J., Lichtenstein, A. H., & Chung, M. C. (2012) · Cited by 25
Limited impact of omega-3 fatty acids in patients with multiple cardiovascular risk factors
Calder, P. C. (2013) · BMJ Evidence-Based Medicine · doi:10.1136/eb-2013-101440 · Cited by 2
Self-citation
Cited by
Djuricic, I., & Calder, P. C. (2021) · Nutrients · doi:10.3390/nu13072421 · Cited by 1,015
Self-citationThe Role of the Gut Microbiota in the Relationship Between Diet and Human Health
Perler, B. K., Friedman, E. S., & Wu, G. D. (2023) · Annual Review of Physiology · doi:10.1146/annurev-physiol-031522-092054 · Cited by 362
Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss
Kirwan, R., McCullough, D., Butler, T., Perez de Heredia, F., Davies, I. G., & Stewart, C. (2020) · GeroScience · doi:10.1007/s11357-020-00272-3 · Cited by 324
Calder, P. C. (2020) · Essays in Biochemistry · doi:10.1042/ebc20190083 · Cited by 321
Self-citationTen things to know about ten cardiovascular disease risk factors
Bays, H. E., Taub, P. R., Epstein, E., Michos, E. D., Ferraro, R. A., Bailey, A. L., Kelli, H. M., Ferdinand, K. C., Echols, M. R., Weintraub, H., et al. (2021) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2021.100149 · Cited by 274
Metadata
- Authors
- Innes, J. K., & Calder, P. C.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-02-18
- Volume
- 21
- Issue
- 4
- Pages
- 1362
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3006875859
- Cited by
- 365
- References
- 94
- FWCI
- 30.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.